Cytiva Cell and Gene Webinars and Podcasts

1. Take The Wheel And Drive Your Oligo Synthesis Where You Want 2/9/2026

   Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

2. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

   Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

3. Hear From The Experts: LNPs Driving The Future Of Cell Therapy 12/12/2025

   Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.

4. Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions 11/20/2025

   Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.

5. Sustainable Vaccine Manufacturing: Securing The Future Of Global Health 7/22/2025

   Explore how next-gen technologies, from mRNA platforms to digital tools, are transforming vaccine manufacturing to make it more sustainable, flexible, and accessible.

6. CRISPR Meets LNPs: A New Era In Cell And Gene Therapies 7/8/2025

   Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.

7. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

   Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

8. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

   Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.

9. Elevating AAV Manufacturing WithTailored Cell Lines 9/19/2024

   Skillfully crafted cell lines can substantially enhance vector purity and yield. Watch to explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.

10. Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles 4/25/2024

    The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?